Annals of Oncology Advance Access originally published online on July 28, 2007
Annals of Oncology 2007 18(9):1569-1577; doi:10.1093/annonc/mdm187
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2007 European Society for Medical Oncology
Up-to-date monitoring of childhood cancer long-term survival in Europe: leukaemias and lymphomas
1 Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany
2 Department of Public Health, Erasmus University Medical Centre, Rotterdam, The Netherlands
3 Clinical Trial Service Unit and Epidemiological Studies Unit, University of Oxford, Oxford, United Kingdom
4 Basque Country Cancer Registry, Vitoria-Gasteiz, Spain
5 INSERM, Villejuif, France
6 Data Analysis and Interpretation Group, International Agency for Research on Cancer, Lyon, France
* Correspondence to: Dr Hermann Brenner, Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Bergheimer Strasse 20, D-69115 Heidelberg, Germany. Tel: +49-6221-548140; Fax: +49-6221-548142; E-mail: h.brenner{at}dkfz-heidelberg.de
Background: In recent decades, following the introduction of effective chemotherapy, the prognosis of children with leukaemia and lymphoma has dramatically improved, but data reflecting further possible improvement achieved in the 1990s are scarce.
Methods: Using the Automated Childhood Cancer Information (ACCIS) database, we carried out a period analysis of 10-year survival for the 1995–99 period. Analyses were carried out by diagnostic groups, age-group at diagnosis, sex and four European regions.
Results: Ten-year survival estimates for the 1995–99 period were 73% for any type of leukaemia, 78% for acute lymphoid leukaemia and 52% for acute non-lymphocytic leukaemia. The corresponding 10-year survival rates for all types of lymphomas, Hodgkin lymphoma, and non-Hodgkin lymphoma were 84, 91 and 79%, respectively. These figures are much higher than those obtained by traditional (cohort-based) methods of survival analysis. A large difference in prognosis is still observed between the East and other parts of Europe.
Conclusion: Major improvement in prognosis for children with leukaemia or lymphoma has been ongoing in Europe during the 1990s, but further monitoring and investments are required to remove the large regional differences between European regions.
Key words: cancer registries, childhood cancer, Europe, leukaemia, lymphoma, survival
Received for publication November 17, 2006. Revision received April 4, 2007. Accepted for publication April 11, 2007.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  V. Arndt, B. Lacour, E. Steliarova-Foucher, C. Spix, A. Znaor, G. Pastore, C. Stiller, and H. Brenner Up-to-date monitoring of childhood cancer long-term survival in Europe: tumours of the sympathetic nervous system, retinoblastoma, renal and bone tumours, and soft tissue sarcomas Ann. Onc., October 1, 2007; 18(10): 1722 - 1733. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Brenner, E. Steliarova-Foucher, and V. Arndt Up-to-date monitoring of childhood cancer long-term survival in Europe: methodology and application to all forms of cancer combined Ann. Onc., September 1, 2007; 18(9): 1561 - 1568. [Abstract] [Full Text] [PDF]
|
|